Targeting Virulence in Staphylococcus aureus by Chemical Inhibition of the Accessory Gene Regulator System In Vivo
Related Experiment Video
Updated: Feb 15, 2026

Methodology for the Study of Horizontal Gene Transfer in Staphylococcus aureus
Published on: March 10, 2017
Akram M Salam1, Cassandra L Quave2,3,4
1Program in Molecular and Systems Pharmacology, Laney Graduate School, Emory University, Atlanta, Georgia, USA.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) presents one of the most serious health concerns worldwide. The WHO labeled it as a "high-priority" pathogen in 2017, also citing the more recently emerged vancomycin-intermediate and -resistant strains. With the spread of antibiotic resistance due in large part to the selective pressure exerted by conventional antibiotics, the use of antivirulence strategies has been recurrently proposed as a promising therapeutic approach. In MRSA, virulence is chiefly controlled by quorum sensing (QS); inhibitors of QS are called quorum quenchers (QQ). In S. aureus, the majority of QS components are coded for by the accessory gene regulator (Agr) system. Although much work has been done to develop QQs against MRSA, only a few studies have progressed to in vivo models. Those studies include both prophylactic and curative models of infection as well as combination treatments with antibiotic. For most, high efficacy is seen at attenuating MRSA virulence and pathogenicity, with some studies showing effects such as synergy with antibiotics and antibiotic resensitization. This minireview aims to summarize and derive conclusions from the literature on the in vivo efficacy of QQ agents in MRSA infection models. In vitro data are also summarized to provide sufficient background on the hits discussed. On the whole, the reported in vivo effects of the reviewed QQs against MRSA represent positive progress at this early stage in drug development. Follow-up studies that thoroughly examine in vitro and in vivo activity are needed to propel the field forward and set the stage for lead optimization.
Insights
Quorum quenchers (QQ) show promise in combating Methicillin-resistant Staphylococcus aureus (MRSA) infections. Studies demonstrate QQ efficacy in vivo, attenuating virulence and showing synergy with antibiotics, advancing antivirulence strategies.
Area of Science:
- Microbiology and Infectious Diseases
- Drug Discovery and Development
- Antimicrobial Resistance
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a high-priority global health threat, exacerbated by rising antibiotic resistance.
- Antivirulence strategies, targeting bacterial pathogenicity rather than viability, offer a promising alternative to conventional antibiotics.
- Quorum sensing (QS) is a key regulator of MRSA virulence, making its inhibitors, quorum quenchers (QQ), potential therapeutic agents.
Purpose of the Study:
- To review and synthesize the existing literature on the in vivo efficacy of quorum quenchers (QQ) against MRSA infection models.
- To assess the progress and potential of QQ agents as a therapeutic strategy for MRSA infections.
- To provide background on in vitro data supporting the discussed QQ agents.
Main Methods:
- Comprehensive literature review of studies investigating quorum quenchers (QQ) in MRSA infection models.
- Inclusion of in vitro data to support the efficacy of selected QQ agents.
- Analysis of studies employing prophylactic, curative, and combination treatment models.
Main Results:
- Several QQ agents have demonstrated significant efficacy in attenuating MRSA virulence and pathogenicity in vivo.
- Some QQ treatments exhibit synergistic effects when combined with conventional antibiotics, including antibiotic resensitization.
- A limited number of QQ studies have progressed to in vivo models, indicating an early stage of development.
Conclusions:
- The in vivo efficacy of reviewed QQ agents against MRSA represents significant progress in developing novel antivirulence therapies.
- QQ agents hold promise for combating MRSA infections, potentially overcoming existing antibiotic resistance mechanisms.
- Further rigorous in vitro and in vivo studies are essential for lead optimization and advancing QQ agents towards clinical application.
Related Concept Videos
Accessory Organs
Epigenetic Regulation
RNA Polymerase II Accessory Proteins
Gene Regulation During Sporulation
Circadian Rhythms and Gene Regulation
Constitutive and Regulated Gene Expression

